| Tag | Content |
|---|
EnhancerAtlas ID | HS182-05748 | Organism | Homo sapiens | Tissue/cell | Spleen | Coordinate | chr13:32621340-32622620 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35410 | chr13:32619657-32621696 | HepG2 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH13I032045 | chr13 | 32619939 | 32622536 |
| Enhancer Sequence | GGTAGCCATT GTTATTAGTA ATTTGCCTAA TTAATGCTTG TCTAAATCCC TCTGTAAGTT 60
AATGGTTTTG TCATGTTGGC TCATTGCCAA GACAGTATGA CCAGGAACCA AAGAGTCTTG 120
GAGCTTTTTT GTGACATCTT CTTGACTTGA GGATCTGAAC TTTACCACTC CCTAGAGAGG 180
ATATTTTGGT AGCAAAGTAC ATTTCTGGAA CTTCAGAAAA TTAACCATCT AAAGATATCC 240
AAGATAGAAT GTGTTCCTTC TAAATTCAGA GCTATGTATG ATGGCTGAAA ATATAACAAG 300
GCATTAGCGT ATGCTACAGT TGCAGCGTTT TCTTTTTCCT TTTTGTTTTT CTTTTTTTCT 360
TTTCTTTTCT TTTTTTTTGG GGGGGGTGCA GAGTTTCACT CTTGTTGCCC AGGCTGGAGT 420
GCAACAGCAT GATCTCGCCT CACTGCAACC TCCACCTCCT GGGTTCAAGT GATTCTCCTG 480
CCTCAGCCTC CCAAGTAGCT GGGATTATAG GCACGCACCA CCACTCCTGG CTAGTTTTTT 540
TGTATTTTTA GTAGAAACAG GATTTCACCA TGTTAGCCAG GCTGGTCTCG AGCTCCTGAC 600
CTCAGGTGAT CTGCCTGCTT CGGCCTCCGA AAGTACTGGG ATTACAGGTG TGAGGCACCA 660
CACCCGGCCC AGTTACAGCA TTTTCTGTGA GCATTTATGT GAATTAAACC TGAAGCGTGA 720
GCTTTTTGGA TTTGGACCAA ACTCTTATCC TGTGTGTATG AGTTTCACTC TAACTGACCC 780
ACTTCCACTT CCCCTTCCCC TACCCTTTCT ACATACTTCC ATTGTAGCAA CAGTGGCATT 840
CTGTAACTGC TTTACCTGTC TGGGTCCCTC TGTGGCTAAG AATCAACCGT CTTTTCATTT 900
TTCTACCCTC TAGCACATCT TAGGGCACAT TGGCTCTGTG AATAATCTGT TAAATATTGA 960
ATGAGTGAAT AAAATCTCTT GAGTGGGTGT GGGAGGTCTG TGCCTAAACT TTGCTAGCAT 1020
GTCGCCCCTC AGTGGATGAG CACCCAGCAA GCAGTAACAG TGTTTTGTCT TTTGGGATCT 1080
TTCTATCTTT TATTCCAAGC AGGAACTCAG CATCTAATCT TAGCTCTGAA GTCTCTTTCC 1140
TCTGTAACCC TCACCTGTTG TTTTGTTTGA GTGAGTTCAA CAAGCTAAAT TGTACCATTG 1200
TGTTCACAGA ACTCTGGGCA GATATGTCCA TGAAAAGAAA AGTGTAGAGT GAAATGATGT 1260
TTTATTTGTA TAATGATCAG 1280
|
| |
|
|
|
